May 12, 2020Hummingbird Bioscience closes US$25M investment with Series B extensionHummingbird Bioscience, an innovative biotherapeutics company focused on the discovery and development of new breakthrough therapies, has...
Dec 16, 2019Hummingbird Bioscience Raises US$19 Million in Series B FinancingFundraising will support the expansion of Hummingbird Bioscience's discovery pipeline and rapid development of its portfolio of targeted...